Search | IOVS | ARVO Journals

Showing 1 – 20 of 38

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Efficacy and Safety of Fluocinolone Acetonide Implant (Iluvien®) in Postoperative Cystoid Macular Edema: ILUCYD study

Karolina Motloch; Aude Couturier; Marie-Noëlle DELYFER; Vivien Vasseur; Benjamin Wolff; Mohamad Issa; Corinne Dot; Michel Weber; Alban Comet; Wolfgang Hitzl; Catherine P Creuzot Garcher; Laurent Kodjikian; Ramin Tadayoni

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4412.

ARVO Annual Meeting Abstract June 2024

Anatomical and visual outcome after post-operative face-down positioning in idiopathic macular holes treated with inverted internal limiting membrane flap technique

Rita Serra; Olivier Loria; Thibaud Mathis; Philippe Denis; Antonio Pinna; Laurent Kodjikian

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4014.

ARVO Annual Meeting Abstract June 2023

Disease control at week 16 of brolucizumab in adult patients with suboptimal anatomically controlled neovascular age related macular degeneration – the SWIFT study

Ramin Tadayoni; Eric Souied; Catherine Creuzot-Garcher; Salomon Y Cohen; Laurent Kodjikian; Stephanie Baillif; Marie-Noelle Delyfer; Michel Weber; Isabelle Aubry-Quenet; Anne Ponthieux; François Devin

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):465.

ARVO Annual Meeting Abstract June 2022

Results of a Delphi consensus study of geographic atrophy (GA) diagnosis and current management

Rishi P Singh; Winfried M K Amoaku; Francesco Bandello; Fred Kuanfu Chen; Frank G Holz; Preeti Joshi; Laurent Kodjikian; José María Ruiz-Moreno; Charles Clifton Wykoff

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1499.

ARVO Annual Meeting Abstract June 2022

Two-year outcome of intravitreal aflibercept injection in vitrectomized eyes with diabetic macular edema.

Thi Ha Chau Tran; Stephane Verdun; Jean François LE ROUIC; Joel Uzzan; Solange Milazzo; Laurent Kodjikian; Ali Erginay

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2510 – F0236.

ARVO Annual Meeting Abstract June 2021

Efficacy and safety of intravitreal aflibercept (IVT-AFL) treat-and-extend (T&E) compared with fixed dosing (q8) for neovascular age-related macular degeneration (nAMD): The AZURE study

Laurent Kodjikian; Lluís Arias Barquet; András Papp; Peter Kertes; Edoardo Midena; Jan Ernest; Rufino Silva; Thomas Schmelter; Tobias Niesen; Sergio Leal

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):425.

ARVO Annual Meeting Abstract June 2020

Efficacy and tolerance of Aflibercept intravitreal injection in vitrectomized eyes with diabetic macular edema.

Ali Erginay; Stephanie BAILLIF; Eric FOURMIAUX; Jean François LEROUIC; Joel UZZAN; Solange Milazzo; Laurent KODJIKIAN; Thi Ha Chau TRAN

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3307.

ARVO Annual Meeting Abstract July 2019

Real-World Use of Intravitreal Aflibercept Injections in Diabetic Macular Edema: 1-Year Interim Results of APOLLON.

Jean-Francois Korobelnik; Laurent Kodjikian; Vincent Daien; Celine Faure; Ramin Tadayoni; Audrey Giocanti-Aurégan; Pascale Massin

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3651.

ARVO Annual Meeting Abstract July 2019

XEN Gel Stent to Treat Intraocular Hypertension After Dexamethasone-Implant Intravitreal Injections: 5 Cases

Amina Rezkallah; Thibaud Mathis; Philippe Denis; Laurent Kodjikian

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3736.

ARVO Annual Meeting Abstract July 2018

Development and validation of a risk-prediction nomogram for poor functional response one year after treatment with anti-VEGF in naive-diabetic macular edema.

Pierre-Henry GABRIELLE; Jacques Bouche-Pillon; Edouard Maupin; Serge Aho-Glele; Ramin Tadayoni; Laurent Kodjikian; Alain M Bron; Pascale Massin; Catherine P Creuzot Garcher

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3615.

ARVO Annual Meeting Abstract June 2017

Regularity of treatment in nAMD: 12-month results of the PERSEUS and RAINBOW studies

Carsten Framme; Laurent KODJIKIAN

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):425.

ARVO Annual Meeting Abstract June 2017

Real-world outcomes with ranibizumab 0.5 mg treatment in French patients with visual impairment due to diabetic macular edema: 12-month results from the 36-month BOREAL-DME study

Catherine P Creuzot Garcher; Pascale Massin; Laurent KODJIKIAN; Jean-Francois Girmens; Cecile DelCourt; Frank Fajnkuchen; Agnès Glacet; Pierre-Jean Guillausseau; Audrey Derveloy; Laetitia FINZI; Patrick Blin; BPE Team

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1915.

ARVO Annual Meeting Abstract June 2017

Real-world outcomes with ranibizumab 0.5 mg in treatment-naïve French patients with visual impairment due to diabetic macular edema: 12-month results from the ETOILE study

Eric Fourmaux; Amélie LECLEIRE-COLLET; Corinne DOT; Marie-Laure LE LEZ; Stéphanie BAILLIF; Ali Erginay; Eric Souied; Philippe GAIN; Laurent KODJIKIAN; Laetitia FINZI

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4625.

ARVO Annual Meeting Abstract June 2017

Real-world outcomes with ranibizumab 0.5 mg treatment in French patients with visual impairment due to macular edema secondary to central retinal vein occlusion: 6-month results from the 24-month BOREAL-CRVO study

Mayer Srour; Agnès Glacet; Jean-Francois Girmens; Laurent KODJIKIAN; Cecile DelCourt; Frank Fajnkuchen; Catherine P Creuzot Garcher; Pascale Massin; Pierre-Jean Guillausseau; Anne Ponthieux; Laetitia FINZI; Angela Grelaud-Boussinot; BPE Team

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4630.

ARVO Annual Meeting Abstract September 2016

Systemic Pharmacodynamic Effects of Anti-Vascular Endothelial Growth Factor (VEGF) Agents in Patients With Wet Age-Related Macular Degeneration

Peter K Kaiser; Laurent Kodjikian; Jean-Francois Korobelnik; Oliver Zeitz; Robert Vitti; Carola Metzig; Christiane Ahlers; Thomas dicioccio; Joachim Hoechel

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3366.

ARVO Annual Meeting Abstract September 2016

Substained intraocular hypertension or steroids-induced Glaucoma after dexamethasone implant (DEX implant) intravitreal injection, myth or reality?

Amina Rezkallah; Laurent Kodjikian; Arianne Macles; Hussam El Chehab; Anne Laure Vie; Emilie Agard; Anh Minh NGuyen; Corinne Dot

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3286.

ARVO Annual Meeting Abstract September 2016

Management of diabetic macular edema with visual impairment in real-life practice in France: findings from the cross-sectional BOREAL DME study

Catherine P Garcher; Pascale G Massin; Frank Fajnkuchen; Agnes Glacet-Bernard; Laurent Kodjikian; Jean-François Maher GIRMENS; Cécile Delcourt; Pierre-Jean Guillausseau; Anne Ponthieux

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):2086.

ARVO Annual Meeting Abstract September 2016

CORRELATION IN RETINAL NERVE FIBER LAYER THICKNESS IN UVEITIS AND HEALTHY EYES USING SCANNING LASER POLARIMETRY AND OPTICAL COHERENCE TOMOGRAPHY

David Bellocq; Laurent Kodjikian; Philippe Denis

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3412.

ARVO Annual Meeting Abstract June 2015

Real Life of Aflibercept In FraNce: oBservatiOnal study in Wet AMD: the RAINBOW study

Salomon Y Cohen; Catherine P Garcher; Jean-Francois Korobelnik; Laurent Kodjikian; Ramin Tadayoni; Michel Weber; Martine Mauget-Faysse; Sam Razavi; Joel Uzzan; ingrid Dufour

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):4601.

ARVO Annual Meeting Abstract June 2015

Dexamethasone intravitreal implant tolerance in OHT and GAO patients : about 3O cases

Anne Laure Vie; Laurent Kodjikian; Ariane Malcles; Hussam El Chehab; Emilie Agard; Corinne Dot

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):200.

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Efficacy and Safety of Fluocinolone Acetonide Implant (Iluvien®) in Postoperative Cystoid Macular Edema: ILUCYD study

Anatomical and visual outcome after post-operative face-down positioning in idiopathic macular holes treated with inverted internal limiting membrane flap technique

Disease control at week 16 of brolucizumab in adult patients with suboptimal anatomically controlled neovascular age related macular degeneration – the SWIFT study

Results of a Delphi consensus study of geographic atrophy (GA) diagnosis and current management

Two-year outcome of intravitreal aflibercept injection in vitrectomized eyes with diabetic macular edema.

Efficacy and safety of intravitreal aflibercept (IVT-AFL) treat-and-extend (T&E) compared with fixed dosing (q8) for neovascular age-related macular degeneration (nAMD): The AZURE study

Efficacy and tolerance of Aflibercept intravitreal injection in vitrectomized eyes with diabetic macular edema.

Real-World Use of Intravitreal Aflibercept Injections in Diabetic Macular Edema: 1-Year Interim Results of APOLLON.

XEN Gel Stent to Treat Intraocular Hypertension After Dexamethasone-Implant Intravitreal Injections: 5 Cases

Development and validation of a risk-prediction nomogram for poor functional response one year after treatment with anti-VEGF in naive-diabetic macular edema.

Regularity of treatment in nAMD: 12-month results of the PERSEUS and RAINBOW studies

Real-world outcomes with ranibizumab 0.5 mg treatment in French patients with visual impairment due to diabetic macular edema: 12-month results from the 36-month BOREAL-DME study

Real-world outcomes with ranibizumab 0.5 mg in treatment-naïve French patients with visual impairment due to diabetic macular edema: 12-month results from the ETOILE study

Real-world outcomes with ranibizumab 0.5 mg treatment in French patients with visual impairment due to macular edema secondary to central retinal vein occlusion: 6-month results from the 24-month BOREAL-CRVO study

Systemic Pharmacodynamic Effects of Anti-Vascular Endothelial Growth Factor (VEGF) Agents in Patients With Wet Age-Related Macular Degeneration

Substained intraocular hypertension or steroids-induced Glaucoma after dexamethasone implant (DEX implant) intravitreal injection, myth or reality?

Management of diabetic macular edema with visual impairment in real-life practice in France: findings from the cross-sectional BOREAL DME study

CORRELATION IN RETINAL NERVE FIBER LAYER THICKNESS IN UVEITIS AND HEALTHY EYES USING SCANNING LASER POLARIMETRY AND OPTICAL COHERENCE TOMOGRAPHY

Real Life of Aflibercept In FraNce: oBservatiOnal study in Wet AMD: the RAINBOW study

Dexamethasone intravitreal implant tolerance in OHT and GAO patients : about 3O cases

To View More...

You must be signed into an individual account to use this feature.